1. RA abrogates hepatic gluconeogenesis and insulin resistance by enhancing IRS-1 and AMPK signalling in experimental type 2 diabetes
   G. Jayanthy et al, 2015, RSC Advances CrossRef
2. Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials
   Cristian Del Bo’ et al, 2023, Nutrients CrossRef
3. Cocoa flavonoids attenuate high glucose-induced insulin signalling blockade and modulate glucose uptake and production in human HepG2 cells
   Isabel Cordero-Herrera et al, 2014, Food and Chemical Toxicology CrossRef
4. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease
   Jie Zhou et al, 2019, Journal of Agricultural and Food Chemistry CrossRef
5. Salubrious Effects of Green Tea Catechins on Fatty Liver Disease: A Systematic Review
   Omar Abunofal et al, 2022, Medicines CrossRef
6. Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges
   Jia Xiao et al, 2013, Hepatobiliary & Pancreatic Diseases International CrossRef
7. Dietary supplement of Yunkang 10 green tea and treadmill exercise ameliorate high fat diet induced metabolic syndrome of C57BL/6 J mice
   Yanzhong Zhang et al, 2020, Nutrition & Metabolism CrossRef
8. Anti-inflammatory activity of natural dietary flavonoids
   Min-Hsiung Pan et al, 2010, Food & Function CrossRef
9. Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis
   Ravirajsinh N. Jadeja et al, 2014, Polyphenols in Human Health and Disease CrossRef
10. (—)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis
    Takafumi Sumi et al, 2013, SpringerPlus CrossRef
11. Potential Biological Effects of (‐)‐Epigallocatechin‐3‐gallate on the Treatment of Nonalcoholic Fatty Liver Disease
    Cheng Chen et al, 2018, Molecular Nutrition & Food Research CrossRef
12. The great potential of flavonoids as candidate drugs for NAFLD
    Liangge Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
13. Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway
    Ui-Jin Bae et al, 2018, The American Journal of Chinese Medicine CrossRef
14. Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects
    Ravirajsinh Jadeja et al, 2014, Evidence-Based Complementary and Alternative Medicine CrossRef
15. Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
    Guoyi Tang et al, 2021, Antioxidants CrossRef
16. PHYTOMEDICINES FOR FATTY LIVER DISEASE AND FUNCTIONAL GASTROINTESTINAL CONDITIONS
    George Q. Li et al, 2015, Phytotherapies CrossRef
17. Research progress on the lipid-lowering and weight loss effects of tea and the mechanism of its functional components
    Ziying Zhang et al, 2023, The Journal of Nutritional Biochemistry CrossRef
18. Epigallocatechin-3-gallate protects against 1,3-dichloro-2-propanol-induced lipid accumulation in C57BL/6J mice
    Jing Lu et al, 2018, Life Sciences CrossRef
19. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds
    Albert Pérez-Martí et al, 2017, Hormone Molecular Biology and Clinical Investigation CrossRef
20. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice
    Lu Gan et al, 2015, Acta Pharmacologica Sinica CrossRef
21. Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients
    Yoshitaka Fukuzawa et al, 2014, Journal of Functional Foods CrossRef
22. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease
    Bregje Van De Wier et al, 2017, Critical Reviews in Food Science and Nutrition CrossRef
23. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms
    I. Rodriguez-Ramiro et al, 2016, Proceedings of the Nutrition Society CrossRef
24. Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo
    Yan Li et al, 2011, Diabetes Research and Clinical Practice CrossRef
25. Nutrition and Genetics in NAFLD: The Perfect Binomium
    Marica Meroni et al, 2020, International Journal of Molecular Sciences CrossRef
26. Therapeutic potential of green tea in nonalcoholic fatty liver disease
    Christopher Masterjohn et al, 2012, Nutrition Reviews CrossRef